Search
01/10/2023
Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
Orgueira, AM, Encinas, MMP, Varela, NAD, Mora, E, Díaz-Beyá, M, Montoro, MJ, Pomares, H, Ramos, F, Tormo, M, Jerez, A, Nomdedeu, JF, Sanchez, CD, Leonor, A, Cárcel, P, Romero, MTC, Xicoy, B, Rivero, E, Barreto, RAD, Diez-Campelo, M, Benlloch, LE, Crucitti, D, Valcárcel, D. Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes. Hemasphere. 2023; 7(10)DOI:10.1097/HS9.0000000000000961. PMID:37841754. IF:11.900(Q1/1D).
01/10/2023
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients
Piñana, JL, Heras, I, Aiello, TF, García-Cadenas, I, Vazquez, L, Lopez-Jimenez, J, Chorao, P, Aroca, C, García-Vidal, C, Arroyo, I, Soler-Espejo, E, López-Corral, L, Avendaño-Pita, A, Arrufat, A, Garcia-Gutierrez, V, Arellano, E, Hernández-Medina, L, González-Santillana, C, Morell, J, Hernández-Rivas, JA, Rodriguez-Galvez, P, Mico-Cerdá, M, Guerreiro, M, Campos, D, Navarro, D, Cedillo, A, Martino, R, Solano, C. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses-Basel. 2023; 15(10)DOI:10.3390/v15102066. PMID:37896843. IF:3.800(Q2/5D).
01/10/2023
Programa de optimización de antibioterapia en infección urinaria por cepas multirresistentes en el servicio de urgencias.
Ruiz-Ramos J, Herrera-Mateo S, Rivera-Martínez MA, Monje-López AE, Hernández-Ontiveros H, Pereia-Batista CS, Martinez-Ysasis YM, Puig-Campmany M. Programa de optimización de antibioterapia en infección urinaria por cepas multirresistentes en el servicio de urgencias.. Revista Espanola de Quimioterapia. 2023; 36(5)DOI:10.37201/req/009.2023. PMID:37458335. IF:1.900(Q3/7D).
01/10/2023
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome
Huerta A., Arjona E., Portoles J., Lopez-Sanchez P., Cavero T., Fernandez-Cusicanqui J., Blasco M., Cabello V., Calvo N., Diaz M., Herrero-Goñi M., Aguirre M., Elías S., Alcaide M.P., Ramos N., Sellares J., Rodríguez de Córdoba S.. On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome. KIDNEY INTERNATIONAL. 2023; 104(4)DOI:10.1016/j.kint.2023.07.020. PMID:37567446. IF:14.800(Q1/1D).
01/10/2023
Using evidence to decision frameworks led to guidelines of better quality and more credible and transparent recommendations
Meneses-Echavez J.F., Bidonde J., Montesinos-Guevara C., Amer Y.S., Loaiza-Betancur A.F., Tellez Tinjaca L.A., Fraile Navarro D., Poklepovic Pericic T., Tokalic R., Bala M.M., Storman D., Swierz M., Zajac J., Flórez I.D., Schünemann H., Flottorp S., Alonso-Coello P.. Using evidence to decision frameworks led to guidelines of better quality and more credible and transparent recommendations. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2023; 162DOI:10.1016/j.jclinepi.2023.07.013. PMID:37517506. IF:7.300(Q1/1D).
29/09/2023
Treatment and long-term outcome in primary nephrogenic diabetes insipidus
Lopez-Garcia, SC, Downie, ML, Kim, JS, Boyer, O, Walsh, SB, Nijenhuis, T, Papizh, S, Yadav, P, Reynolds, B, Decramer, S, Besouw, M, Carrascosa, MP, La Scola, C, Trepiccione, F, Ariceta, G, Hummel, A, Dossier, C, Sayer, JA, Konrad, M, Keijzer-Veen, MG, Awan, A, Basu, B, Chauveau, D, Madariaga, L, Koster-Kamphuis, L, Furlano, M, Zacchia, M, Marzuillo, P, Tse, Y, Dursun, I, Pinarbasi, AS, Tramma, D, Hoorn, EJ, Gokce, I, Nicholls, K, Eid, LA, Sartz, L, Riordan, M, Hooman, N, Printza, N, Bonny, O, Sancho, PA, Schild, R, Sinha, R, Guarino, S, Jimenez, VM, Peña, LR, Belge, H, Devuyst, O, Wlodkowski, T, Emma, F, Levtchenko, E, Knoers, NVAM, Bichet, DG, Schaefer, F, Kleta, R, European NDI Consortium, Bockenhauer, D. Treatment and long-term outcome in primary nephrogenic diabetes insipidus. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(10)DOI:10.1093/ndt/gfaa243. PMID:33367818. IF:4.800(Q1/2D).
26/09/2023
Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism.
Ward J, Le NQ, Suryakant S, Brody JA, Amouyel P, Boland A, Bown R, Cullen B, Debette S, Deleuze JF, Emmerich J, Graham N, Germain M, Anderson JJ, Pell JP, Lyall DM, Lyall LM, Smith DJ, Wiggins KL, Soria JM, Souto JC, Morange PE, Smith NL, Trégouët DA, Sabater-Lleal M, Strawbridge RJ. Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism.. Blood Advances. 2023; 7(18)DOI:10.1182/bloodadvances.2023010562. PMID:37399490. IF:7.400(Q1/2D).
26/09/2023
Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study.
Moreno C, Solman IG, Tam CS, Grigg A, Scarfò L, Kipps TJ, Srinivasan S, Mali RS, Zhou C, Dean JP, Szafer-Glusman E, Choi M. Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study.. Blood Advances. 2023; 7(18)DOI:10.1182/bloodadvances.2023010236. PMID:37315225. IF:7.400(Q1/2D).
25/09/2023
Burden of refractory and unexplained chronic cough on patients' lives: a cohort study.
Puente-Maestu L, Dávila I, Quirce S, Crespo-Lessmann A, Martínez-Moragón E, Sola J, Nieto ML, González-Barcala FJ, Cea-Calvo L, Sánchez-Jareño M, Rivas-Pardinas C, Domingo C. Burden of refractory and unexplained chronic cough on patients' lives: a cohort study.. Erj Open Research. 2023; 9(5)DOI:10.1183/23120541.00425-2023. PMID:37753282. IF:4.300(Q1/3D).
24/09/2023
Research on missed nursing care during the COVID-19 pandemic: A scoping review.
Zabaleta-Del-Olmo E, Santesmases-Masana R, Martín-Payo R, Romero-Collado À, Zamora-Sánchez JJ, Urpí-Fernández AM, Gonzalez-Del-Rio M, Lumillo-Gutiérrez I, Sastre-Rus M, Jodar-Fernández L, Hernández-Martínez-Esparza E. Research on missed nursing care during the COVID-19 pandemic: A scoping review.. Worldviews on Evidence-Based Nursing. 2023; 20(6)DOI:10.1111/wvn.12682. PMID:37743584. IF:3.400(Q1/1D).
24/09/2023
Frailty and mortality: Utility of Frail-VIG index in ED short-stay units for older adults.
Blázquez-Andión M, Montiel-Dacosta JA, Rizzi-Bordigoni M, Acosta-Mejuto B, Moliné-Pareja A, Ris-Romeu J, Puig-Campmany M. Frailty and mortality: Utility of Frail-VIG index in ED short-stay units for older adults.. ARCHIVES OF GERONTOLOGY AND GERIATRICS. 2023; 115DOI:10.1016/j.archger.2023.105208. PMID:37774490. IF:3.500(Q2/4D).
23/09/2023
Clinical characteristics and outcome of amaurosis fugax due to transient retinal ischemia: Results from a contemporary cohort.
Martinez-Viguera A, Xuclà-Ferrarons T, Collet R, Olmedo-Saura G, Martí-Fàbregas J, Izquierdo A, Martínez-Domeño A, Prats-Sánchez L, Guasch-Jiménez M, Guisado-Alonso D, Ramos-Pachón A, Camps-Renom P. Clinical characteristics and outcome of amaurosis fugax due to transient retinal ischemia: Results from a contemporary cohort.. Journal of Stroke & Cerebrovascular Diseases. 2023; 32(11)DOI:10.1016/j.jstrokecerebrovasdis.2023.107335. PMID:37748428. IF:2.000(Q3/6D).
22/09/2023
Influence of body mass index on recurrence of atrial fibrillation after electrical cardioversion.
Ligero C, Bazan V, Guerra JM, Rodríguez-Mañero M, Viñolas X, Alegret JM. Influence of body mass index on recurrence of atrial fibrillation after electrical cardioversion.. PLoS One. 2023; 18(9)DOI:10.1371/journal.pone.0291938. PMID:37738256. IF:(Q/D).
22/09/2023
Influence of type of household on prognosis at one year in patients =65 years attending hospital emergency departments in Spain. The EDEN-6 study.
Alquézar-Arbé A, Osorio GI, Jacob J, García-Lamberechts EJ, Piñera Salmerón P, Llorens P, Burillo-Putze G, Requena AC, Gil A, Fernández C, Aguiló S, Jiménez S, Escudero Blázquez B, Rosendo Mesino D, Mojarro EM, Vaswani-Bulchand A, Rodríguez-Cabrera M, Alarcón Martínez P, Gioya GD, Alemany González FX, González Tejera M, Bóveda García M, Espinosa Fernández B, Llopis F, Suero Méndez C, González Del Castillo J, Miró Ò. Influence of type of household on prognosis at one year in patients =65 years attending hospital emergency departments in Spain. The EDEN-6 study.. MATURITAS. 2023; 178DOI:10.1016/j.maturitas.2023.107852. PMID:37774596. IF:3.900(Q1/2D).
20/09/2023
Impact of a PROgram of Cardiovascular nursE interventionS in a VALVular haEmodynamic Unit (PROCESS-VALVE) on Quality Indicators: A Quasi-Experimental Ambispective Study.
Valverde Bernal J, Martínez-Soler F, Berga Congost G, Martínez Pérez J, Asmarats L, Moreno Arroyo C. Impact of a PROgram of Cardiovascular nursE interventionS in a VALVular haEmodynamic Unit (PROCESS-VALVE) on Quality Indicators: A Quasi-Experimental Ambispective Study.. International Journal of General Medicine. 2023; 16DOI:10.2147/IJGM.S412369. PMID:37750105. IF:2.100(Q2/3D).
20/09/2023
Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis.
Puig N, Solé A, Aguilera-Simon A, Griñán R, Rotllan N, Camps-Renom P, Benitez S. Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis.. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(18)DOI:10.3390/ijms241814325. PMID:37762627. IF:4.900(Q1/3D).
19/09/2023
Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease.
Gasca-Salas C, Trompeta C, López-Aguirre M, Rodríguez Rojas R, Clarimon J, Dols-Icardo O, El Bounasri S, Guida P, Mata-Marín D, Hernández-Fernández F, Marras C, García-Cañamaque L, Plaza de Las Heras I, Obeso I, Vela L, Fernández-Rodríguez B. Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease.. JOURNAL OF NEUROIMAGING. 2023; 33(6)DOI:10.1111/jon.13156. PMID:37726927. IF:2.300(Q2/5D).
18/09/2023
Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement: A Prognostic Systematic Review and Meta-Analysis.
Jiménez-Xarrié E, Asmarats L, Roqué-Figuls M, Millán X, Li CHP, Fernández-Peregrina E, Sánchez-Ceña J, Massó van Roessel A, Maestre Hittinger ML, Paniagua P, Arzamendi D. Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement: A Prognostic Systematic Review and Meta-Analysis.. Journal of Clinical Medicine. 2023; 12(18)DOI:10.3390/jcm12186025. PMID:37762965. IF:3.000(Q1/2D).
18/09/2023
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction.
Bertaina M, Morici N, Frea S, Garatti L, Briani M, Sorini C, Villanova L, Corrada E, Sacco A, Moltrasio M, Ravera A, Tedeschi M, Bertoldi L, Lettino M, Saia F, Corsini A, Camporotondo R, Colombo CNJ, Bertolin S, Rota M, Oliva F, Iannaccone M, Valente S, Pagnesi M, Metra M, Sionis A, Marini M, De Ferrari GM, Kapur NK, Pappalardo F, Tavazzi G. Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction.. ESC Heart Failure. 2023; DOI:10.1002/ehf2.14510. PMID:37723131. IF:3.200(Q2/3D).
18/09/2023
Improved phenotypic classification of male infertility to promote discovery of genetic causes
Wyrwoll, MJ, van der Heijden, GW, Krausz, C, Aston, KI, Kliesch, S, McLachlan, R, Ramos, L, Conrad, DF, O'Bryan, MK, Veltman, JA, Tüttelmann, F. Improved phenotypic classification of male infertility to promote discovery of genetic causes. Nature Reviews Urology. 2023; DOI:10.1038/s41585-023-00816-0. PMID:37723288. IF:12.100(Q1/1D).